Recardio's Positive Phase 2 Results Presented as Latebreaker at World Congress on Acute Heart Failure 2022 in Madrid
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Latebreaker Session News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Latebreaker Session. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Latebreaker Session Today - Breaking & Trending Today
Recardio's Phase 2 Results Will Be Presented as Latebreaker at World Congress on Heart Failure 2022
Recardio Inc., a clinical-stage life science company developing regenerative therapies for cardiovascular diseases, announced that the study results of Recardio's Phase 2 clinical study in Acute Myocardial Infarction will be presented on Saturday, May 21, 2022, during the Latebreaker Session at the World Congre...
Source: pharmiweb.com